Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1990-10-23
1992-05-19
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 31557
Patent
active
051149710
ABSTRACT:
11-epi PGF.sub.2 alpha esters are employed in treating glaucoma or ocular hypertension.
REFERENCES:
patent: 4599353 (1986-07-01), Bito
Resul Bahram
Stjernschantz Johan W.
Gerstl Robert
Kabi Pharmacia AB
Philpitt Fred
LandOfFree
Prostaglandin derivatives for the treatment of glaucoma or ocula does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin derivatives for the treatment of glaucoma or ocula, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin derivatives for the treatment of glaucoma or ocula will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2417721